Neurawell Therapeutics

Miami, United States

NeuraWell Therapeutics engages in clinical-stage research and development company for central nervous system (CNS) disorders.

$1.6M raised

Jun 2024

Venture - Series Unknown

Clinical Trials Health Care Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Neurawell Therapeutics

How much funding has Neurawell Therapeutics raised?

Neurawell Therapeutics has raised $1.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.

Where is Neurawell Therapeutics headquartered?

Neurawell Therapeutics is headquartered in Miami, United States.

What does Neurawell Therapeutics do?

NeuraWell Therapeutics engages in clinical-stage research and development company for central nervous system (CNS) disorders.

What stage is Neurawell Therapeutics at?

Neurawell Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 7, 2024.

MLA

"Neurawell Therapeutics — Funding & Investors." VCBacked, June 7, 2024, https://www.vcbacked.co/company/neurawell-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). Neurawell Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/neurawell-therapeutics

Wikipedia (cite web)

{{cite web |title=Neurawell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neurawell-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 7, 2024.